{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:43:56Z","timestamp":1786538636636,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.radonc.2025.111240","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:06:45Z","timestamp":1761696405000},"page":"111240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quality assurance of contouring and dosimetric consistency in the GETUG-AFU 31 salvage prostate stereotactic reirradiation trial"],"prefix":"10.1016","volume":"214","author":[{"given":"Marion","family":"Tonneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Bartau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lacornerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Brihoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6019-7309","authenticated-orcid":false,"given":"David","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111240_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102206","article-title":"Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: an ESTRO ACROP Delphi consensus","volume":"98","author":"Jereczek-Fossa","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2025.111240_b0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026666","article-title":"GETUG-AFU 31: a phase I\/II multicentre study evaluating the safety and efficacy of salvage stereotactic radiation in patients with intraprostatic tumour recurrence after external radiation therapy-study protocol","volume":"9","author":"Pasquier","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.radonc.2025.111240_b0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euo.2023.01.009","article-title":"The safety and efficacy of salvage stereotactic radiation therapy in patients with intraprostatic tumor recurrence after previous external radiation therapy: phase 1 results from the GETUG-AFU 31 Study","volume":"6","author":"Pasquier","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.radonc.2025.111240_b0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.radonc.2016.09.009","article-title":"Uncertainties in volume delineation in radiation oncology: a systematic review and recommendations for future studies","volume":"121","author":"Vinod","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111240_b0025","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2022.11.021","article-title":"Assessing interobserver variability in the delineation of structures in radiation oncology: a systematic review","volume":"115","author":"Guzene","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111240_b0030","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.radonc.2018.04.015","article-title":"Contouring of prostate tumors on multiparametric MRI: evaluation of clinical delineations in a multicenter radiotherapy trial","volume":"128","author":"van Schie","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111240_b0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00066-015-0812-8","article-title":"A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: reducing the interobserver variability in multicentre clinical studies","volume":"191","author":"Schimek-Jasch","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111240_b0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.eururo.2010.12.009","article-title":"Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting","volume":"59","author":"Dickinson","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2025.111240_b0045","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1007\/s00330-018-5819-y","article-title":"Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapy","volume":"29","author":"Dinis Fernandes","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2025.111240_b0050","article-title":"Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography\/multiparametric magnetic resonance imaging","volume":"31","author":"Grefve","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111240_b0055","doi-asserted-by":"crossref","unstructured":"Dhar A, Cendejas-Gomez J de J, Castro Mendez L, Boldt G, McArthur E, Zamboglou C, et al. Using multiparametric Magnetic Resonance Imaging and Prostate Specific Membrane Antigen Positron Emission Tomography to detect and delineate the gross tumour volume of intraprostatic lesions - A systematic review and meta-analysis. Radiother Oncol. 2024;192:110070. Doi: 10.1016\/j.radonc.2023.110070.","DOI":"10.1016\/j.radonc.2023.110070"},{"key":"10.1016\/j.radonc.2025.111240_b0060","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00259-021-05604-9","article-title":"Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET\/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study","volume":"49","author":"Bodar","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2025.111240_b0065","doi-asserted-by":"crossref","unstructured":"Nguyen L, Song Y, Dornisch A, Baxter M, Barrett T, Dale AM, et al. PURE-MRI: An International Study Assessing Physician Accuracy in Delineating the Prostate and Urethra on Prostate MRI [Internet]. medRxiv; 2025 [cited 2025 May 28]. p. 2025.04.23.25326296. Doi: 10.1101\/2025.04.23.25326296.","DOI":"10.1101\/2025.04.23.25326296"},{"key":"10.1016\/j.radonc.2025.111240_b0070","article-title":"Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRI","volume":"25","author":"Adair Smith","year":"2022","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111240_b0075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.radonc.2015.04.012","article-title":"Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation","volume":"115","author":"Steenbergen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111240_b0080","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.3390\/biomedicines11123309","article-title":"Inter-rater variability of prostate lesion segmentation on multiparametric prostate MRI","volume":"11","author":"Jeganathan","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.radonc.2025.111240_b0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jmrs.485","article-title":"Visualising the urethra for prostate radiotherapy planning","volume":"68","author":"Richardson","year":"2021","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.radonc.2025.111240_b0090","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/mp.15983","article-title":"Fully automated segmentation of prostatic urethra for MR-guided radiation therapy","volume":"50","author":"Xu","year":"2023","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2025.111240_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102076","article-title":"An update on the role of mpMRI and 68Ga-PSMA PET imaging in primary and recurrent prostate cancer","volume":"22","author":"Bagheri","year":"2024","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.radonc.2025.111240_b0100","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00066-024-02254-2","article-title":"Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO\/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery","volume":"200","author":"Brunner","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111240_b0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijrobp.2022.01.008","article-title":"Planning Benchmark Study for Stereotactic Body Radiation Therapy of Liver Metastases: results of the DEGRO\/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery","volume":"113","author":"Moustakis","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025052442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025052442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:23:21Z","timestamp":1786537401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025052442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":21,"alternative-id":["S0167814025052442"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111240","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality assurance of contouring and dosimetric consistency in the GETUG-AFU 31 salvage prostate stereotactic reirradiation trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111240"}}